Navigation Links
MultiVu Video Feed: POSITIVE PHASE 3 TRIAL DATA FOR INVESTIGATIONAL NEW MIGRAINE TREATMENT PRESENTED IN LATE-BREAKING SESSION AT 14th ANNUAL INTERNATIONAL HEADACHE SOCIETY CONGRESS
Date:9/10/2009

LEVADEX Analysis Shows Potential to Treat a Broad Spectrum of Migraine ***UPDATED SATELLITE COORDINATES***

Migraine is a common, debilitating neurological disorder that affects approximately 30 million people in the United States, according to the National Headache Foundation. Limitations of oral triptans, the class of prescription drugs widely used for migraines, include slow onset of significant pain relief between 45 and 90 minutes, substantial variability in patient response and side effects such as heightened blood pressure.

MAP Pharmaceuticals, Inc. will present analysis of data from the efficacy portion of the first Phase 3 trial of LEVADEX(TM) at the 14th Congress of the International Headache Society. Data from this Phase 3 trial show the potential of LEVADEX to be effective in treating acute migraine as well as a broad spectrum of migraine, including migraine subpopulations that are often resistant to current therapies, migraine with moderate and severe pain, migraine with nausea and vomiting, and migraine with and without aura. LEVADEX is an orally inhaled migraine therapy that patients administer themselves using the company's proprietary TEMPO(R) inhaler.

    SATELLITE FEED:
    Thursday, September 10th, 2009
    2:00 PM - 2:15 PM ET
    Galaxy 19
    C-Band
    Transponder 10
    Downlink Freq. 3900 Horizontal

NEWS: New Data Presented at the International Headache Society's Annual Congress Suggests New, Investigational Migraine Treatment Could Help Provide Relief for 30 Million Sufferers in the U.S.

FORMAT: B-roll and Soundbites

ADDITIONAL RESOURCES: Video, contact information and more available at: http://www.prnewswire.com/broadcast/40023/consumer.html


    SOUNDBITES:
    * Dr. Stephen Silberstein,
'/>"/>
SOURCE  MAP Pharmaceuticals, Inc.
Copyright©2009 PR Newswire.
All rights reserved

1

GOOD

Page: 1 2 

Related medicine technology :

1. MultiVu Video Feed: Major Trial Demonstrates Comparable Accuracy of Virtual Colonoscopy and Standard Colonoscopy
2. MultiVu Video Feed: Large, Long-Term Veterans Affairs Diabetes Trial (VADT) Reveals Important Cardiovascular Safety News on AVANDIA
3. Video: MADIT-CRT Trial Results Provide Clinical Evidence That Cardiac Resynchronization Therapy Significantly Slows Heart Failure Progression
4. Video: FDA Approves INVEGA(R) SUSTENNA(TM) for the Acute and Maintenance Treatment of Schizophrenia
5. Medigus and Tower Semiconductor Announce Worlds Smallest Medical Video Camera Based on Advanced CMOS Image Sensor
6. Video: New Dove(R) Body Washes with NutriumMoisture(TM) Restore Skins Natural Moisture
7. Video: Phase III Study Data With Vandetanib (Zactima(TM)) in Patients With Advanced Non-Small Cell Lung Cancer (NSCLC) Presented at American Society of Clinical Oncology
8. Video: Data on More Than 15 Novartis Oncology Compounds at ASCO Highlight Progress Toward Targeted Therapies for Diverse Tumor Types
9. Video: UCB Launches Vimpat(R) in the U.S. for Add-On Treatment of Epilepsy in Adults
10. Video: Partnership Unites UCB with Consumer Product Innovator OXO(R)
11. VIDEO from Medialink and the Epilepsy Foundation: New Study Suggests Different Versions of the Same Epilepsy Medication Can Be Harmful
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:12/15/2009)... LAWRENCE, Mass., Dec. 15 OBP Medical ... comfort and overall patient satisfaction in hospitals. ,, ... measuring the positive effects of OBP Medical,s Under ... hospital stay. A hospital wide survey is comparing ... of their stay while wearing Under Johnnies(TM) against ...
(Date:12/14/2009)... Fujirebio Diagnostics Inc., a Malvern-based diagnostics ... Year by the Eastern Technology Council at a ... Philadelphia on Thursday, December 3, 2009. ... region,s largest technology and life sciences trade association. ... and Life Sciences Community, the awards are a ...
(Date:12/14/2009)... WASHINGTON, Dec. 14 Following is a ... the Consumer Healthcare Products Association (CHPA), regarding today,s ... (NIDA,s) Monitoring the Future survey: ,, "Findings released ... speak to the need for continued efforts to ... need to talk to their teens about medicine ...
Breaking Medicine Technology:Under Johnnies(TM) Proven To Increase Patient Satisfaction by OBP Medical Inc. 2Fujirebio Diagnostics Named Life Sciences Company of the Year 2Statement From the Consumer Healthcare Products Association(CHPA) on Annual Monitoring the Future Survey on Drug Abuse 2Statement From the Consumer Healthcare Products Association(CHPA) on Annual Monitoring the Future Survey on Drug Abuse 3Drug Combo May Offer Best Relief for Nerve Pain 58527 1Drug Combo May Offer Best Relief for Nerve Pain 58527 2Australian study sheds light on kidney repair and disease 10181 1Australian study sheds light on kidney repair and disease 10181 2Cardinal Health Foundation Invites Health Care Providers to Apply for 241 Million in Grants to Improve Efficiency Quality of Care 58524 1Cardinal Health Foundation Invites Health Care Providers to Apply for 241 Million in Grants to Improve Efficiency Quality of Care 58524 2
... Feb. 5 Joseph F. Finn, Jr.,CPA, the Assignee ... The Committee for Orphan Drug Products of the European ... for the,prevention of oral mucositis (OM) in head and ... mucositis during radiation therapy of head and,neck cancers is ...
... Calif., Feb. 5 Alexza,Pharmaceuticals, Inc. (Nasdaq: ... Phase 1 clinical trial with AZ-007 (Staccato(R) zaleplon). ... the treatment of insomnia,patients who have difficulty falling ... the night and have difficulty falling back asleep. ...
Other Medicine Technology:ActivBiotics Receives Orphan Drug Designation from the European Medicines Agency for Superoxide Dismutase Mimetic, M40403, in Oral Mucositis Indication 2ActivBiotics Receives Orphan Drug Designation from the European Medicines Agency for Superoxide Dismutase Mimetic, M40403, in Oral Mucositis Indication 3Alexza Initiates AZ-007 (Staccato(R) Zaleplon) Phase 1 Clinical Trial and Updates Clinical Pipeline Development Status 2Alexza Initiates AZ-007 (Staccato(R) Zaleplon) Phase 1 Clinical Trial and Updates Clinical Pipeline Development Status 3Alexza Initiates AZ-007 (Staccato(R) Zaleplon) Phase 1 Clinical Trial and Updates Clinical Pipeline Development Status 4Alexza Initiates AZ-007 (Staccato(R) Zaleplon) Phase 1 Clinical Trial and Updates Clinical Pipeline Development Status 5Alexza Initiates AZ-007 (Staccato(R) Zaleplon) Phase 1 Clinical Trial and Updates Clinical Pipeline Development Status 6Alexza Initiates AZ-007 (Staccato(R) Zaleplon) Phase 1 Clinical Trial and Updates Clinical Pipeline Development Status 7
(Date:12/15/2009)... and Spanish scientists have found the first potential immunological ... infected by the pandemic H1N1 virus. , The ... hospitalized patients, 15 outpatients and 15 control subjects in ... July and August 2009. Researchers from the Hospital Clinico ... Network found high levels of a molecule called interleukin ...
(Date:12/15/2009)... Although seen as a potential heart disease therapy, ... of a transfer protein may not be effective, a ... Human Nutrition Research Center on Aging (USDA HNRCA) at ... found an association between low plasma cholesterol ester transfer ... in the Framingham Heart Study population. , CETP is ...
(Date:12/15/2009)... to control the volume without compromising sound-quality or comfort. ... ... 2009 -- EarPeace ( www.earpeace.com ) is redefining hearing protection ... three different skin-tone colors. "As a big fan of live-music ... was looking for a way to continue my active lifestyle ...
(Date:12/15/2009)... Workers, Compensation Carrier Confirms PMSI as Solution Provider of ... ... Tampa, FL (Vocus) December 15, 2009 -- PMSI, one ... of specialty products and services for the workers’ compensation ... has decided to renew its pharmacy services (retail and ...
(Date:12/15/2009)... Fillers and Large Volume Injections Dangerous , ... ... The popularity and hype surrounding buttock augmentation and other large-volume ... U.S. borders is an alarming and potentially deadly trend, cautions ... fillers such as polymethylmethacrylate (PMMA), silicone, and polyacrylimide used in ...
Breaking Medicine News(10 mins):Health News:First immunological clue to why some H1N1 patients get very ill or die 2Health News:Low cholesterol transfer protein activity associated with heart disease risk 2Health News:EarPeace Introduces Elegant, High-fidelity Hearing Protection Solution 2Health News:KEMI Renews Contract With PMSI 2Health News:Physicians Coalition for Injectable Safety Warns Buttock-Boosting Injections Risky and Deadly 2Health News:Physicians Coalition for Injectable Safety Warns Buttock-Boosting Injections Risky and Deadly 3Health News:Physicians Coalition for Injectable Safety Warns Buttock-Boosting Injections Risky and Deadly 4
... Researchers have found a gene variant that raises a ... and painful condition attributed to inflammation of the gastrointestinal ... earlier results of a German study that identified the ... the disease.Crohns disease is a chronic and painful condition ...
... Changes to the UK licensing laws have trebled the number ... reveals research in Emergency Medicine Journal . ,The ... the clock, took effect in November 2005. ,The ... of binge drinking and associated crime and disorder, and boost ...
... has revealed that the star had a miscarriage in 2005 . ... Kutcher ever since they tied the knot in September 2005, and ... Ghost star did in fact become pregnant, but she lost the ... have kids of her own. Demi and Ashton have been trying ...
... Paul McCartney for his decision to boycott cancer charities that ... has supported cancer charities since his first wife Linda died ... planning to decline financial support to organisations that practice vivisection. ... discovering that a number of charities close to his heart ...
... belief that male circumcision can reduce HIV infection rates ... will be told next week . ,David ... conference to be held in Sydney from July 22-25, ... in HIV prevention. ,"We always knew that ...
... an alarming depletion of ground water levels in the country ... of water table. ,The Central Groundwater Board ... water level at various places across the country and identified ... this score, a senior official said. ,"The constant ...
Other Medicine News:Health News:Gene Variants for Crohn's Disease Identified 2Health News:Gene Variants for Crohn's Disease Identified 3Health News:UK Licensing Law Changes Have Trebled Overnight Alcohol Related Visits to Emergency Care 2Health News:Male Circumcision can Cut HIV Infection, Studies Show 2Health News:Groundwater Levels Depleting Alarmingly in India 2
... many surgeons turn it down confidently knowing ... the going gets tough. More important are the ... and the technologically advanced fan we build into ... ups and overheating. The result is dependable, extreme ...
Mounted on a sturdy, molded headband,the Classic has a fully adjustable crown,strap and cushioning that adds to,your comfort....
Mounted on a fully adjustable molded,headband with crown strap and comfort,cushions, the sturdy Trueview Classic is,lightweight, comfortable and durable....
Mounted on a sturdy, molded headband,the Classic has a fully adjustable,crown strap and cushioning that adds,to your comfort....
Medicine Products: